A multidisciplinary approach for autologous breast reconstruction: A narrative (re)view for better management
Creators
- 1. Sackler School of Medicine, Tel-Aviv University (Israel)
- 2. GROW-School for Oncology and Developmental Biology (Maastro), Maastricht University (Netherlands)
- 3. Breast Cancer Radiation Therapy Unit, at Sheba Medical Center, Ramat Gan (Israel)
- 4. General Surgery B and The Meirav Breast Center, Sheba Medical Center (Israel)
- 5. University of Antwerp, Faculty of Medicine and Health Sciences, 2610 Wilrijk-Antwerp (Belgium)
- 6. Iridium Kankernetwerk, 2610 Wilrijk-Antwerp (Belgium)
- 7. Department of Experimental Clinical Oncology, Aarhus University Hospital (Denmark)
- 8. Department of Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht (Netherlands)
Description
Breast reconstruction and oncoplastic surgery have become an important part of breast cancer care. The use of autologous breast reconstruction (ABR) has evolved significantly with advances in microsurgery, aiming to reduce donor site complications and improve cosmesis. For years, immediate-ABR was considered a contraindication if postmastectomy irradiation (PMRT) was planned. As a result of de-escalation of axillary surgery the indication of PMRT are increasing along-side with observations that PMRT in the setting of ABR is not contraindicated. Surgical techniques may result in different amount and areas of breast residual glandular tissue and patient selection is important to reduce potential residual disease. Meticulus radiation planning is important to potentially reduce complications without compromising oncologic outcomes. Surgical techniques change constantly in aim to improve aesthetic results but should most importantly maintain priority to the oncological indications. By multidisciplinary team work with a comprehensive understanding of each discipline, we can preserve the accomplishments of breast surgery in the setting of PMRT, without compromising disease control.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radonc.2021.01.036Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2021.01.036;
- PII
- S0167814021060448;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 157
- Journal Page Range
- p. 263-271
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54013873
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- AESTHETICS; ANIMAL TISSUES; IRRADIATION; MAMMARY GLANDS; NEOPLASMS; PATIENTS; PLANNING; RADIOTHERAPY; SURGERY
- Descriptors DEC
- BODY; DISEASES; GLANDS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier B.V. All rights reserved.